Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 31, pseudogene (RNU1-31P) is a non-coding RNA gene classified as a **pseudogene** of the U1 small nuclear RNA (snRNA) family[3][1]. Pseudogenes resemble real genes but contain sequence changes, deletions, or insertions that normally prevent them from encoding functional products[1]. While some U1 snRNA pseudogenes are transcribed and may contribute variant snRNAs to ribonucleoprotein complexes, many have no clear biological function and are not considered therapeutic targets[1][3]. There is currently no evidence that RNU1-31P itself plays a role in disease, drug response, or cellular signaling; it is not a protein-coding gene, nor is it classified as an enzyme, receptor, transporter, or other established drug target class[3][1]. RNU1-31P is best described as a pseudogene related to the U1 snRNA locus, and not as a biological target for therapeutic intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 31, pseudogene (RNU1-31P).